Tue Sep 17 06:50:21 UTC 2024: ## Lower Doses of Anti-Cancer Drugs Boost Immunotherapy Effectiveness, Study Finds
**Perth, Australia** – A groundbreaking study from the Harry Perkins Institute of Medical Research has revealed that significantly lowering the dosage of anti-cancer drugs may enhance the effectiveness of immunotherapy.
Researchers discovered that administering anti-cancer drugs at a dose one hundred times lower than standard treatment levels could actually stabilize the tumor microenvironment, making it more receptive to immunotherapy. This innovative approach could potentially lead to improved outcomes for cancer patients.
The findings, which have yet to be published in a peer-reviewed journal, offer a promising new direction in the fight against cancer. The research team believes that this discovery could pave the way for more effective and less toxic cancer treatments.
First Piper 